CCM Investment Group LLC purchased a new stake in Premier, Inc. (NASDAQ:PINC - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 36,540 shares of the company's stock, valued at approximately $699,000.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Cooper Financial Group acquired a new position in Premier in the 1st quarter valued at about $221,000. Invesco Ltd. grew its position in shares of Premier by 5.7% during the 1st quarter. Invesco Ltd. now owns 760,939 shares of the company's stock worth $14,671,000 after purchasing an additional 41,342 shares in the last quarter. Atlas Capital Advisors Inc. acquired a new position in shares of Premier during the 1st quarter worth approximately $125,000. Charles Schwab Investment Management Inc. grew its position in shares of Premier by 4.6% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,897,424 shares of the company's stock worth $36,582,000 after purchasing an additional 84,016 shares in the last quarter. Finally, New Age Alpha Advisors LLC grew its position in shares of Premier by 5,893.3% during the 1st quarter. New Age Alpha Advisors LLC now owns 231,523 shares of the company's stock worth $4,464,000 after purchasing an additional 227,660 shares in the last quarter. Institutional investors and hedge funds own 74.41% of the company's stock.
Analysts Set New Price Targets
A number of research analysts have issued reports on the stock. Robert W. Baird increased their target price on shares of Premier from $19.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, May 15th. Piper Sandler increased their target price on shares of Premier from $19.00 to $24.00 and gave the stock a "neutral" rating in a research report on Wednesday, May 21st. Finally, Canaccord Genuity Group increased their target price on shares of Premier from $19.00 to $22.00 and gave the stock a "hold" rating in a research report on Thursday, May 8th. Seven analysts have rated the stock with a hold rating, According to MarketBeat, Premier has a consensus rating of "Hold" and an average price target of $22.20.
Read Our Latest Report on PINC
Premier Stock Performance
Shares of Premier stock traded up $0.10 on Thursday, reaching $24.63. 2,201,500 shares of the stock were exchanged, compared to its average volume of 1,587,693. The firm's 50 day moving average is $21.96 and its 200-day moving average is $20.76. Premier, Inc. has a one year low of $17.23 and a one year high of $24.74. The firm has a market cap of $2.03 billion, a PE ratio of 43.21 and a beta of 0.56.
Insider Buying and Selling
In related news, Director John T. Bigalke sold 1,137 shares of the stock in a transaction that occurred on Wednesday, June 4th. The shares were sold at an average price of $23.03, for a total value of $26,185.11. Following the completion of the transaction, the director owned 28,673 shares of the company's stock, valued at $660,339.19. This represents a 3.81% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Helen M. Boudreau sold 2,000 shares of the firm's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $22.88, for a total transaction of $45,760.00. Following the transaction, the director directly owned 18,668 shares of the company's stock, valued at $427,123.84. The trade was a 9.68% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company's stock.
About Premier
(
Free Report)
Premier, Inc, together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions.
See Also

Before you consider Premier, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Premier wasn't on the list.
While Premier currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.